Average Co-Inventor Count = 6.80
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Samsung Electronics Co., Ltd. (8 from 131,611 patents)
2. National Cancer Center (2 from 222 patents)
10 patents:
1. 8673573 - Use of eIF3m for the diagnosis and treatment of cancer
2. 8554487 - Method and apparatus for analyzing genotype data
3. 8541237 - Method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging
4. 7914996 - Polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide
5. 7833710 - Polynucleotide associated with breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing breast cancer using the same
6. 7732139 - Multiple SNP for diagnosing cardiovascular disease, microarray and kit comprising the same, and method of diagnosing cardiovascular disease using the same
7. 7666603 - Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
8. 7638274 - Polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide
9. 7635559 - Polynucleotide associated with a type II diabetes mellitus comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for analyzing polynucleotide using the same
10. 7517650 - Method of diagnosing breast cancer and compositions therefor